← Solid-Tumor Biomarkers
Solid-tumor biomarker
CA-125
A biomarker used in the clinical assessment and monitoring of ovarian cancer.
Product overview
What it is.
- A blood test that measures CA-125 (cancer antigen 125), a tumor marker often raised in ovarian cancer.
- Most common use: checking whether ovarian-cancer treatment is working and whether the cancer has returned.
- May be combined with imaging and other tests to assess a pelvic mass, or in people at very high risk of ovarian cancer.
- Not a routine screening test: non-cancer conditions such as endometriosis or menstruation can also raise CA-125.
Portfolio information
From the original portfolio.
Content review draft
The former site describes CA-125 in treatment response and recurrence monitoring; it is not presented as a stand-alone diagnosis.
This page preserves the former site’s product information for review. It does not establish current Canadian availability, approved indications, performance, or prescribing information. Request verified documentation before relying on it.
Request verified informationExplore this area